Volume 28, Number 2—February 2022
Research
Burden of Tick-Borne Encephalitis, Sweden
Table 1
Variable | Within 3 y before TBE | After TBE |
||
---|---|---|---|---|
Within 1 y | Within 3 y | Within 5 y | ||
Days hospitalized | ||||
Case cohort, mean (no.) | 1.35 (2,228) | 11.50 (2,274) | 12.73 (1,863) | 14.69 (1,466) |
Referent cohort, mean (no.) | 2.07 (6,684) | 1.12 (6,822) | 3.27 (5,589) | 5.64 (4,404) |
Difference in means |
0.28 |
10.38† |
9.46† |
9.05† |
Specialist outpatient visits | ||||
Case cohort, mean (no.) | 3.92 (2,228) | 3.65 (2,270) | 6.78 (1,863) | 9.45 (1,466) |
Referent cohort, mean (no.) | 3.31 (6,684) | 1.22 (6,810) | 3.53 (5,583) | 5.74 (4,398) |
Difference in means |
0.62† |
2.42† |
3.25† |
3.71† |
Days of sick leave | ||||
Case cohort, mean (no.) | 63.3 (1406) | 66.0 (1,434) | 122.6 (1,169) | 144.0 (902) |
Referent cohort, mean (no.) | 51.4 (2765) | 10.7 (2,802) | 45.9 (2,286) | 78.1 (1,793) |
Difference in means |
11.82‡ |
55.32† |
76.66† |
65.85† |
Primary healthcare visits | ||||
Case cohort, mean (no.) | 9.19 (280) | 6.44 (276) | 14.43 (228) | 23.29 (175) |
Referent cohort, mean (no.) | 10.55 (779) | 3.90 (763) | 11.54 (638) | 19.55 (502) |
Difference in means | −1.36 | 2.54† | 2.89§ | 3.74 |
*TBE, tick-borne encephalitis. †Significance at the 1% level. ‡Significance at the 5% level. §Significance at the 10% level.
Page created: December 02, 2021
Page updated: January 24, 2022
Page reviewed: January 24, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.